Kiadis draws €20 million from bridge loan with Sanofi

Amsterdam, The Netherlands, January 14, 2021 Kiadis Pharma N.V. (Kiadis or the Company) (Euronext Amsterdam and Brussels: KDS) today announces that the Company has drawn 20 million from the Companys bridge loan with Sanofi (the Bridge Loan) to bridge Kiadis capital needs through the closing of the acquisition by Sanofi.